The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
Background and aim Nonalcoholic fatty liver disease (NAFLD) involves a spectrum of liver disorders, ranging from benign steatosis to nonalcoholic steato-hepatitis to fibrosis and cirrhosis. This study aims to evaluate the diagnostic validity of using s.autotaxin (ATX) as a noninvasive bio-marker of...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-10-01
|
| Series: | Al-Azhar Assiut Medical Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/azmj.azmj_10_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841525310659493888 |
|---|---|
| author | Muhammad Abdel-Gawad Hamdiy Mahfouz Mona Abdelmeguid Gehad M.A.-A. Hassan Marwa Khalaf Hani S. Aboalam |
| author_facet | Muhammad Abdel-Gawad Hamdiy Mahfouz Mona Abdelmeguid Gehad M.A.-A. Hassan Marwa Khalaf Hani S. Aboalam |
| author_sort | Muhammad Abdel-Gawad |
| collection | DOAJ |
| description | Background and aim
Nonalcoholic fatty liver disease (NAFLD) involves a spectrum of liver disorders, ranging from benign steatosis to nonalcoholic steato-hepatitis to fibrosis and cirrhosis. This study aims to evaluate the diagnostic validity of using s.autotaxin (ATX) as a noninvasive bio-marker of fibrosis in NAFLD cases as compared with Controlled Attenuation Parameter and scoring systems of hepatic steatosis.
Patients and methods
This cross-sectional study was performed at Al-Azhar University Hospitals and Assiut Liver Center, conducted on 100 adult men and women patients who showed evidence of fatty liver disease between September 2020 and March 2021.
Results
There were 66 patients without fibrosis (group I) and 34 patients with fibrosis [group II] with significant change between the two groups regarding NAFLD fibrosis score [P=0.002] and grade of fibrosis by fibroscan (P< 0.001) but nonsignificant as regard FIB4 score, BARD score, and Steatosis. The mean ATX level in NAFLD cases was 81.37±14.56 ng/ml. It was noticed that patients with fibrosis showed higher ATX levelsl in comparison with cases with no fibrosis (P= 0.027). Regarding lab data, higher cholesterol, low-density lipoproteins, lower high-density lipoproteins level, and triglycerides levels were in males (P< 0.05) with nonsignificant change regarding fasting glucose, hemoglobin A1C, AST, ALT, AST/ALT ratio, Albumin, HB, white blood cell, and Platelet (P>0.05).
Conclusion
ATX showed poor validity in the prediction of hepatic fibrosis in cases with NAFLD disease, there was a statistically significant increase prevalence of hypertension among females compared with males, an important change was found among males and females regarding NAFLD fibrosis-score, and grade of fibrosis by fibro-scan. |
| format | Article |
| id | doaj-art-92f94344825548f3add4d7c2b3a29083 |
| institution | Kabale University |
| issn | 1687-1693 |
| language | English |
| publishDate | 2023-10-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Al-Azhar Assiut Medical Journal |
| spelling | doaj-art-92f94344825548f3add4d7c2b3a290832025-01-17T15:36:55ZengWolters Kluwer Medknow PublicationsAl-Azhar Assiut Medical Journal1687-16932023-10-0121420220710.4103/azmj.azmj_10_24The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver diseaseMuhammad Abdel-GawadHamdiy MahfouzMona AbdelmeguidGehad M.A.-A. HassanMarwa KhalafHani S. AboalamBackground and aim Nonalcoholic fatty liver disease (NAFLD) involves a spectrum of liver disorders, ranging from benign steatosis to nonalcoholic steato-hepatitis to fibrosis and cirrhosis. This study aims to evaluate the diagnostic validity of using s.autotaxin (ATX) as a noninvasive bio-marker of fibrosis in NAFLD cases as compared with Controlled Attenuation Parameter and scoring systems of hepatic steatosis. Patients and methods This cross-sectional study was performed at Al-Azhar University Hospitals and Assiut Liver Center, conducted on 100 adult men and women patients who showed evidence of fatty liver disease between September 2020 and March 2021. Results There were 66 patients without fibrosis (group I) and 34 patients with fibrosis [group II] with significant change between the two groups regarding NAFLD fibrosis score [P=0.002] and grade of fibrosis by fibroscan (P< 0.001) but nonsignificant as regard FIB4 score, BARD score, and Steatosis. The mean ATX level in NAFLD cases was 81.37±14.56 ng/ml. It was noticed that patients with fibrosis showed higher ATX levelsl in comparison with cases with no fibrosis (P= 0.027). Regarding lab data, higher cholesterol, low-density lipoproteins, lower high-density lipoproteins level, and triglycerides levels were in males (P< 0.05) with nonsignificant change regarding fasting glucose, hemoglobin A1C, AST, ALT, AST/ALT ratio, Albumin, HB, white blood cell, and Platelet (P>0.05). Conclusion ATX showed poor validity in the prediction of hepatic fibrosis in cases with NAFLD disease, there was a statistically significant increase prevalence of hypertension among females compared with males, an important change was found among males and females regarding NAFLD fibrosis-score, and grade of fibrosis by fibro-scan.https://journals.lww.com/10.4103/azmj.azmj_10_24autotaxinfatty liver diseasefibrosis scorehepatic steatosisnonalcoholic steato-hepatitisvalidity |
| spellingShingle | Muhammad Abdel-Gawad Hamdiy Mahfouz Mona Abdelmeguid Gehad M.A.-A. Hassan Marwa Khalaf Hani S. Aboalam The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease Al-Azhar Assiut Medical Journal autotaxin fatty liver disease fibrosis score hepatic steatosis nonalcoholic steato-hepatitis validity |
| title | The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| title_full | The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| title_fullStr | The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| title_full_unstemmed | The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| title_short | The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| title_sort | validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| topic | autotaxin fatty liver disease fibrosis score hepatic steatosis nonalcoholic steato-hepatitis validity |
| url | https://journals.lww.com/10.4103/azmj.azmj_10_24 |
| work_keys_str_mv | AT muhammadabdelgawad thevalidityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT hamdiymahfouz thevalidityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT monaabdelmeguid thevalidityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT gehadmaahassan thevalidityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT marwakhalaf thevalidityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT hanisaboalam thevalidityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT muhammadabdelgawad validityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT hamdiymahfouz validityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT monaabdelmeguid validityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT gehadmaahassan validityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT marwakhalaf validityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease AT hanisaboalam validityofserumautotaxinasapredictorofhepaticfibrosisinpatientswithnonalcoholicfattyliverdisease |